Covid infection plus a vaccine helps people fend off variants, study suggests

The study adds to the body of evidence suggesting existing vaccines and boosters may offer some protection against the Omicron variant.
A woman receives her second dose of the Pfizer Covid-19 vaccination (PA)
PA Wire
Jane Kirby7 December 2021

People are more able to fend off coronavirus variants if they have had Covid previously plus a vaccine, new research suggests.

US experts analysed data on people who had recovered from natural infection earlier in the pandemic and found that having a Covid vaccine enabled them to produce high-quality antibodies that could act against variants.

These antibodies were more powerful than those produced by either natural infection or vaccine alone.

The team, from the University of California Los Angeles, said the research suggested booster jabs could help against variants by “improving not only antibody quantity, but also quality”.

The results suggest that booster vaccinations may help improve efficacy against spike variants through improving not only antibody quantity, but also quality

University of California Los Angeles researchers

The study did not look specifically at the Omicron variant but adds to the body of evidence suggesting existing vaccines and boosters may offer some protection.

Writing in the journal of the American Society For Microbiology, the team said: “We confirmed that some mutations reduce the ability of antibodies to neutralise the spike protein, whether the antibodies were from past infection or vaccination.

“Upon retesting the previously infected persons after vaccination, their antibodies gained the same ability to neutralise mutated spike as the original spike, suggesting that the combination of infection and vaccination drove the production of enhanced antibodies to reach a maximal level of potency.

“Whether this can be accomplished by vaccination alone remains to be determined, but the results suggest that booster vaccinations may help improve efficacy against spike variants through improving not only antibody quantity, but also quality.”

An area of the virus spike protein called the receptor binding domain (RBD) is known to enable the Covid virus to invade a host cell.

This region is also a critical target for antibodies but random mutations in the RBD mean it is an ever-changing target.

In the new study, scientists compared anti-RBD antibodies in the blood of some people to the ability of the antibodies to neutralise the virus.

In people who had never had Covid but who had received a vaccine, antibodies were less effective against mutations in the Beta and Gamma variants than against the original Wuhan strain of the virus.

Similarly, when researchers analysed blood samples from people who had suffered Covid before May 2020 – and before the first confirmation of variants – they had reduced protection against variants.

The experts said this suggests that both mild infection and vaccines produce antibodies that still leave a person vulnerable to new variants.

However, those who suffered Covid before May 2020 and who had a vaccine a year later had antibodies that were just as potent against variants as against the original Wuhan strain.

Immunologist and lead researcher Dr Otto Yang said finding the ideal mix of antibodies could help guide future efforts to tackle Covid-19.

Create a FREE account to continue reading

eros

Registration is a free and easy way to support our journalism.

Join our community where you can: comment on stories; sign up to newsletters; enter competitions and access content on our app.

Your email address

Must be at least 6 characters, include an upper and lower case character and a number

You must be at least 18 years old to create an account

* Required fields

Already have an account? SIGN IN

By clicking Create Account you confirm that your data has been entered correctly and you have read and agree to our Terms of use , Cookie policy and Privacy policy .

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged in

MORE ABOUT